期刊
OPEN FORUM INFECTIOUS DISEASES
卷 9, 期 2, 页码 -出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofab648
关键词
HIV; antiretroviral therapy; drug resistance; dolutegravir; integrase strand transfer inhibitor
Multiclass high-level transmitted HIV drug resistance is uncommon, but this case highlights the successful treatment with dolutegravir, tenofovir, and emtricitabine even with extensive resistance. It emphasizes the high resistance barrier of dolutegravir and the residual antiviral activity of nucleoside reverse transcriptase inhibitors.
Multiclass high-level transmitted HIV drug resistance is uncommon, and the selection of the optimal initial antiretroviral drug regimen may be challenging. We report a case of extensive transmitted multiclass resistance successfully treated with dolutegravir, tenofovir, and emtricitabine even though the baseline genotype demonstrated full susceptibility to only 1 drug class, integrase strand transfer inhibitors. Our case highlights both the high resistance barrier of dolutegravir and the residual antiviral activity of nucleoside reverse transcriptase inhibitors despite extensive resistance on genotype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据